Statin Market Report

Statin Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Nov 17, 2019
  • PAGES：149
  • REPORT CODE：GMM384191
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Statin market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period.

    This report presents the market size and development trends by detailing the Statin market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Statin market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Statin industry and will help you to build a panoramic view of the industrial development.

    Statin Market, By Type:

    • Type 1

    • Type 2

    • Type 3

    Statin Market, By Application:

    • End-User 1

    • End-User 2

    • End-User 3

    Some of the leading players are as follows:

    • GlaxoSmithKline

    • Merck & Co, Inc

    • Aurobindo Pharma

    • GlaxoSmithKline plc

    • Abbvie

    • Livzon

    • Cerenis Therapeutics

    • Merz Pharmaceuticals

    • Abbott

    • Kowa

    • JX Pharmaceuticals

    • AstraZeneca

    • BC World Pharm

    • Novartis

    • Zydus Cadila

    • HanAll BioPharma

    • Torrent Pharmaceuticals

    • CKD Bio

    • Lupin

    • SUN Pharma

    • Merck

    • Cipla

    • Concord Biotech

    • Pfizer

    • Mylan

    • Teva

    • CJ HealthCare Corporation

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Statin Market: Technology Type Analysis

    • 4.1 Statin Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Statin Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Type 1

      • 4.3.2 Type 2

      • 4.3.3 Type 3

    5 Statin Market: Product Analysis

    • 5.1 Statin Product Market Share Analysis, 2018 & 2026

    • 5.2 Statin Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Statin Market: Application Analysis

    • 6.1 Statin Application Market Share Analysis, 2018 & 2026

    • 6.2 Statin Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 End-User 1

      • 6.3.2 End-User 1

      • 6.3.3 End-User 3

    7 Statin Market: Regional Analysis

    • 7.1 Statin Regional Market Share Analysis, 2018 & 2026

    • 7.2 Statin Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 GlaxoSmithKline

      • 9.1.1 GlaxoSmithKline Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Merck & Co, Inc

      • 9.2.1 Merck & Co, Inc Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Aurobindo Pharma

      • 9.3.1 Aurobindo Pharma Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 GlaxoSmithKline plc

      • 9.4.1 GlaxoSmithKline plc Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Abbvie

      • 9.5.1 Abbvie Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Livzon

      • 9.6.1 Livzon Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Cerenis Therapeutics

      • 9.7.1 Cerenis Therapeutics Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Merz Pharmaceuticals

      • 9.8.1 Merz Pharmaceuticals Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Abbott

      • 9.9.1 Abbott Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Kowa

      • 9.10.1 Kowa Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 JX Pharmaceuticals

      • 9.11.1 JX Pharmaceuticals Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 AstraZeneca

      • 9.12.1 AstraZeneca Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 BC World Pharm

      • 9.13.1 BC World Pharm Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Novartis

      • 9.14.1 Novartis Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Zydus Cadila

      • 9.15.1 Zydus Cadila Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 HanAll BioPharma

      • 9.16.1 HanAll BioPharma Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

    • 9.17 Torrent Pharmaceuticals

      • 9.17.1 Torrent Pharmaceuticals Company overview

      • 9.17.2 Financial performance

      • 9.17.3 Product benchmarking

      • 9.17.4 Strategic initiatives

      • 9.17.5 SWOT analysis

    • 9.18 CKD Bio

      • 9.18.1 CKD Bio Company overview

      • 9.18.2 Financial performance

      • 9.18.3 Product benchmarking

      • 9.18.4 Strategic initiatives

      • 9.18.5 SWOT analysis

    • 9.19 Lupin

      • 9.19.1 Lupin Company overview

      • 9.19.2 Financial performance

      • 9.19.3 Product benchmarking

      • 9.19.4 Strategic initiatives

      • 9.19.5 SWOT analysis

    • 9.20 SUN Pharma

      • 9.20.1 SUN Pharma Company overview

      • 9.20.2 Financial performance

      • 9.20.3 Product benchmarking

      • 9.20.4 Strategic initiatives

      • 9.20.5 SWOT analysis

    • 9.21 Merck

      • 9.21.1 Merck Company overview

      • 9.21.2 Financial performance

      • 9.21.3 Product benchmarking

      • 9.21.4 Strategic initiatives

      • 9.21.5 SWOT analysis

    • 9.22 Cipla

      • 9.22.1 Cipla Company overview

      • 9.22.2 Financial performance

      • 9.22.3 Product benchmarking

      • 9.22.4 Strategic initiatives

      • 9.22.5 SWOT analysis

    • 9.23 Concord Biotech

      • 9.23.1 Concord Biotech Company overview

      • 9.23.2 Financial performance

      • 9.23.3 Product benchmarking

      • 9.23.4 Strategic initiatives

      • 9.23.5 SWOT analysis

    • 9.24 Pfizer

      • 9.24.1 Pfizer Company overview

      • 9.24.2 Financial performance

      • 9.24.3 Product benchmarking

      • 9.24.4 Strategic initiatives

      • 9.24.5 SWOT analysis

    • 9.25 Mylan

      • 9.25.1 Mylan Company overview

      • 9.25.2 Financial performance

      • 9.25.3 Product benchmarking

      • 9.25.4 Strategic initiatives

      • 9.25.5 SWOT analysis

    • 9.26 Teva

      • 9.26.1 Teva Company overview

      • 9.26.2 Financial performance

      • 9.26.3 Product benchmarking

      • 9.26.4 Strategic initiatives

      • 9.26.5 SWOT analysis

    • 9.27 CJ HealthCare Corporation

      • 9.27.1 CJ HealthCare Corporation Company overview

      • 9.27.2 Financial performance

      • 9.27.3 Product benchmarking

      • 9.27.4 Strategic initiatives

      • 9.27.5 SWOT analysis

     

    The List of Tables and Figures (Totals 87 Figures and 154 Tables)

    • Figure Type 1 Statin market, 2015 - 2026 (USD Million)

    • Figure Type 2 Statin market, 2015 - 2026 (USD Million)

    • Figure Type 3 Statin market, 2015 - 2026 (USD Million)

    • Figure End-User 1 market, 2015 - 2026 (USD Million)

    • Figure End-User 2 market, 2015 - 2026 (USD Million)

    • Figure End-User 3 market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Statin market, by country, 2015 - 2026 (USD Million)

    • Table North America Statin market, by type, 2015 - 2026 (USD Million)

    • Table North America Statin market, by product, 2015 - 2026 (USD Million)

    • Table North America Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Statin market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Statin market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Statin market, by type, 2015 - 2026 (USD Million)

    • Table Canada Statin market, by product, 2015 - 2026 (USD Million)

    • Table Canada Statin market, by application, 2015 - 2026 (USD Million)

    • Table Europe Statin market, by country, 2015 - 2026 (USD Million)

    • Table Europe Statin market, by type, 2015 - 2026 (USD Million)

    • Table Europe Statin market, by product, 2015 - 2026 (USD Million)

    • Table Europe Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Statin market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Statin market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Statin market, by type, 2015 - 2026 (USD Million)

    • Table Germany Statin market, by product, 2015 - 2026 (USD Million)

    • Table Germany Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Statin market, by type, 2015 - 2026 (USD Million)

    • Table France Statin market, by product, 2015 - 2026 (USD Million)

    • Table France Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Statin market, by type, 2015 - 2026 (USD Million)

    • Table Italy Statin market, by product, 2015 - 2026 (USD Million)

    • Table Italy Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Statin market, by type, 2015 - 2026 (USD Million)

    • Table Spain Statin market, by product, 2015 - 2026 (USD Million)

    • Table Spain Statin market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Statin market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Statin market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Statin market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Statin market, by type, 2015 - 2026 (USD Million)

    • Table China Statin market, by product, 2015 - 2026 (USD Million)

    • Table China Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Statin market, by type, 2015 - 2026 (USD Million)

    • Table Japan Statin market, by product, 2015 - 2026 (USD Million)

    • Table Japan Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Statin market, by type, 2015 - 2026 (USD Million)

    • Table India Statin market, by product, 2015 - 2026 (USD Million)

    • Table India Statin market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Statin market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Statin market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Statin market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Statin market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Statin market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Statin market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Statin market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Statin market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Statin market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Statin market, by application, 2015 - 2026 (USD Million)

    • Table MEA Statin market, by country, 2015 - 2026 (USD Million)

    • Table MEA Statin market, by type, 2015 - 2026 (USD Million)

    • Table MEA Statin market, by product, 2015 - 2026 (USD Million)

    • Table MEA Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Statin market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Statin market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Statin market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Statin market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Statin market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Statin market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merck & Co, Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Aurobindo Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GlaxoSmithKline plc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Abbvie Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Livzon Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cerenis Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merz Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Abbott Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Kowa Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table JX Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BC World Pharm Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Zydus Cadila Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table HanAll BioPharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Torrent Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CKD Bio Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lupin Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table SUN Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cipla Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Concord Biotech Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Mylan Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Teva Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CJ HealthCare Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US